During the past decade, HagaZiekenhuis - Locatie Leyweg conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HagaZiekenhuis - Locatie Leyweg" #1 sponsor was "Commissie Voor Klinisch Toegepast Onderzoek" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HagaZiekenhuis - Locatie Leyweg" #1 collaborator was "ALMANAC Trialists Group" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Borstkanker Onderzoeksgroup Nederland" with 1 trials as a collaborator and "Grup per l'Estudi dels Limfomes de Catalunya i Balears" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "HagaZiekenhuis - Locatie Leyweg" are "Coronary Artery Disease" (4 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Aortic Valve Replacement" (1 trials). Many other conditions were trialed in "HagaZiekenhuis - Locatie Leyweg" in a lesser frequency.

Most popular intervention types in "HagaZiekenhuis - Locatie Leyweg" are "Device" (11 trials), "Drug" (10 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "filgrastim" (4 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "vincristine sulfate" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "HagaZiekenhuis - Locatie Leyweg" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "HagaZiekenhuis - Locatie Leyweg". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in HagaZiekenhuis - Locatie Leyweg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HagaZiekenhuis - Locatie Leyweg, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".